Table 2.
Procedural characteristics | Treated patients (N = 72) | |
---|---|---|
Procedural time (min), median [25th–75th percentile] | 60.0 [50.0–75.0] | |
Amount of contrast used (mL), median [25th–75th percentile] | 80.5 [61.3–140.0] | |
Unilateral procedure, n (%) | 5 (6.9) | |
Renal denervation system | ||
Covidien OneSHOT™ (RF), n (%) | 2 (2.8) | |
Paradise (US), n (%) | 14 (19.4) | |
St. Jude EnligHTN (RF), n (%) | 23 (31.9) | |
Symplicity Flex™ (RF), n (%) | 10 (13.9) | |
Symplicity Spyral™ (RF), n (%) | 19 (26.4) | |
Vessix (RF), n (%) | 4 (5.6) | |
Number of ablations | LRA | RRA |
Covidien OneSHOT™ (RF), median [25th–75th percentile] | 1.0 [1.0–1.0] | 1.0 [1.0–1.0] |
Paradise (US), median [25th–75th percentile] | 3.0 [2.0–3.0] | 3.0 [2.0–3.0] |
St. Jude EnligHTN (RF), median [25th–75th percentile] | 8.0 [8.0–10.3] | 8.0 [8.0–9.0] |
Symplicity Flex™ (RF), median [25th–75th percentile] | 4.5 [4.0–5.8] | 5.0 [5.0–6.0] |
Symplicity Spyral™ (RF), median [25th–75th percentile] | 12.0 [10.0–15.5] | 9.0 [6.0–12.0] |
Vessix (RF), median [25th–75th percentile] | 4.0 [3.3–5.0] | 4.5 [0.8–8.0] |
US ultrasound, RF radiofrequency, LRA Left Renal Artery, RRA Right Renal Artery
*Unilateral procedure due to anatomical difficulties on the untreated side